✦ LIBER ✦

A randomized, double-blind, placebo-controlled study of the safety and tolerance of regadenoson in subjects with stage 3 or 4 chronic kidney disease

✍ Scribed by Karthik Ananthasubramaniam; Robert Weiss; Bruce McNutt; Barbara Klauke; Kathleen Feaheny; Stan Bukofzer

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A randomized, double-blind, placebo-cont

✍ Bruce M. Prenner MD, Stan Bukofzer MBBCh, MMed (Int), Sarah Behm BS, Kathleen Fe 📂 Article 📅 2012 🏛 Springer 🌐 English ⚖ 343 KB

A MULTICENTER, DOUBLE-BLIND, RANDOMIZED,

✍ Karthikeyan Ananthasubramaniam; Robert Weiss; Barbara Klauke; Bruce McNutt; Kath 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 243 KB

Safety, Tolerability and Pharmacokinetic

📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 211 KB

Safety of regadenoson, a selective adeno

✍ Gregory S. Thomas; Bruce R. Tammelin; George L. Schiffman; Rudy Marquez; Deborah 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 687 KB

Efficacy and Safety of Omega-3 for Treat

✍ Mohammad Reza Safarinejad 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 379 KB

Safety, tolerability and efficacy of int

✍ M. Cantillon; E. Vause; D. Sykes; M. Tagoe 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 41 KB